
|
Your Doctor Does Not Likely Understand
How To Interpret Thyroid Blood Tests Properly!
Thyroid
function tests have always presented doctors with difficulties in their
interpretation. Laboratory testing is often misleading due to the
complexity and inherent shortcomings of the tests themselves.
Many doctors not having an adequate understanding of what the test
results mean, will often make incorrect assumptions based on them or
interpret them too strictly. A narrow interpretation of thyroid function
testing leads to many people not being treated for sub-clinical
hypothyroidism.
|

The classic medical model states hypothyroidism in adults is almost always
caused by an autoimmune disease (called Hashimoto’s disease), in which the
body’s immune system reacts against the thyroid gland. The damaged gland is
unable to produce normal amounts of T3 and T4. This type of thyroid disease
is much more common in women than in men. But as you read below you'll see
the model is out-dated.

The big myth that persists regarding thyroid diagnosis is that an elevated
TSH level is always required before a diagnosis of hypothyroidism can be
made. Normally, the pituitary gland will secrete TSH in response to a low
thyroid hormone level. Thus an elevated TSH level would typically suggest an
underactive thyroid.

Many physicians regard hypothyroidism as far more common than is generally
acknowledged. Many individuals currently being treated for hypothryoidism
are actually undertreated, because of excessive reliance on the
ultrasensitive serum thyroid stimulating (TSH) level and the use of a single
thyroid hormone, thyroxine (T4), in its treatment. A recent estimate of the
widespread prevalence of primary hypothyroidism suggests a figure of 9-10%
in the United States. Only about 10% of those thus identified as hypothyroid
admitted to being diagnosed and treated.


The Stop Patient Abuse Now coalition today announced that it will organize
consumer and patient groups across the country to initiate a series of class
action lawsuits against pharmaceutical companies that prevent competition
and endanger public health. The strategy is intended to raise the financial
stakes for drug manufacturers that engage in anti-competitive or
anti-consumer behavior in order to avoid competition.

Mary Shomon, received a copy of a letter from the FDA that had officially
denied Synthroid's request to bypass new drug application and be declared
"generally recognized as safe and effective." The letter outlined various
concerns of Synthroid's stability, potency and reliability for years.

Synthroid has a long history of manufacturing problems, subpotency concerns,
and stability and reliability issues, says a letter sent to Synthroid's
manufacturer from the FDA, and just released to the public. -- June 5, 2001
A majority of people experiencing physical and emotional problems falls
outside the "medical/disease" model. They can be classified as having
sub-clinical conditions, i.e. falling within the normal medical ranges, but
experiencing real physical and emotional symptoms. This is particularly true
in relation to thyroid dysfunction.
Many people suffer a wide variety of symptoms that have one common
denominator: low metabolic energy. This most commonly involves two of the
"primary players" in the endocrine system - the adrenal and thyroid glands.
This article explains the relationship of these two important glands and how
we can diagnose which organ is causing the problem.

Here's your chance to change the face of health care. Your opinion and most
importantly your ACTION CAN and DOES make a difference. We've provided many
links to on-line petitions that only take a few minutes to complete.
Take this
preliminary
to see if your condition could respond to treatment.
|